Companies / Protara Therapeutics, Inc. / Activity
Activity — Protara Therapeutics, Inc.
31 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Apr 1, 2026 | Zummo Jacqueline Executive | Sell | Common Stock | $118.9K | -23K -19.06% | 95,961 0.16% of shares | medium |
| Jan 20, 2026 | Shefferman Jesse CEO | Other | Common Stock | $91.4K | -16K -1.56% | 1,030,564 1.74% of shares | low |
| Jan 26, 2026 | Shefferman Jesse CEO | Other | Common Stock | $58.2K | -9K -0.85% | 1,021,832 1.73% of shares | low |
| Jan 20, 2026 | Zummo Jacqueline Executive | Other | Common Stock | $36.8K | -7K -5.10% | 122,283 0.21% of shares | low |
| Jun 2, 2026 | Conkling William Executive | Other | Common Stock | $26.1K | -6K -7.91% | 69,992 0.12% of shares | low |
| Jan 26, 2026 | Zummo Jacqueline Executive | Other | Common Stock | $24.8K | -4K -3.05% | 118,559 0.20% of shares | low |
| Jan 26, 2026 | Fabbio Patrick Executive | Other | Common Stock | $21.8K | -3K -4.84% | 64,115 0.11% of shares | low |
| Jan 20, 2026 | Fabbio Patrick Executive | Other | Common Stock | $17.2K | -3K -4.35% | 67,376 0.11% of shares | low |
| Jan 20, 2026 | Fry Hannah Executive | Other | Common Stock | $11.9K | -2K -4.60% | 44,180 0.07% of shares | low |
| Jan 26, 2026 | Fry Hannah Executive | Other | Common Stock | $9.7K | -1K -3.30% | 42,723 0.07% of shares | low |
| Apr 8, 2026 | Zummo Jacqueline Executive | Sell | Common Stock | $6.1K | -1K -1.18% | 94,827 0.16% of shares | low |
| Jan 16, 2026 | Shefferman Jesse CEO | Grant | Common Stock | $0 | +87K +9.06% | 1,046,886 1.77% of shares | low |
| Jan 16, 2026 | Zummo Jacqueline Executive | Grant | Common Stock | $0 | +30K +30.35% | 128,861 0.22% of shares | low |
| Jan 16, 2026 | Fabbio Patrick Executive | Grant | Common Stock | $0 | +28K +65.98% | 70,439 0.12% of shares | low |
| Jan 16, 2026 | Conkling William Executive | Grant | Common Stock | $0 | +26K +52.00% | 76,000 0.13% of shares | low |
| Jan 16, 2026 | Fry Hannah Executive | Grant | Common Stock | $0 | +10K +25.81% | 46,312 0.08% of shares | low |
| Jan 16, 2026 | Nicacio Leonardo Viana Executive | Grant | Common Stock | $0 | +26K +49.83% | 78,181 0.13% of shares | low |
| Jun 15, 2026 | Levy Richard S Director | Grant | Stock Option (Right to Buy) | — | +31K | 31,000 0.05% of shares | low |
| Jun 15, 2026 | Solomon Michael Edward Director | Grant | Stock Option (Right to Buy) | — | +31K | 31,000 0.05% of shares | low |
| Jun 15, 2026 | Smith Cynthia Director | Grant | Stock Option (Right to Buy) | — | +31K | 31,000 0.05% of shares | low |
| Jun 15, 2026 | Huang Jane Director | Grant | Stock Option (Right to Buy) | — | +31K | 31,000 0.05% of shares | low |
| Jun 15, 2026 | Garceau Roger Director | Grant | Stock Option (Right to Buy) | — | +31K | 31,000 0.05% of shares | low |
| Jun 15, 2026 | Flannelly Barry P Director | Grant | Stock Option (Right to Buy) | — | +31K | 31,000 0.05% of shares | low |
| Jun 15, 2026 | Sargen Gregory Director | Grant | Stock Option (Right to Buy) | — | +31K | 31,000 0.05% of shares | low |
| Jun 15, 2026 | Beshar Luke M Director | Grant | Stock Option (Right to Buy) | — | +31K | 31,000 0.05% of shares | low |
| Jan 16, 2026 | Shefferman Jesse CEO | Grant | Stock Option (Right to Buy) | — | +524K | 524,000 0.89% of shares | low |
| Jan 16, 2026 | Zummo Jacqueline Executive | Grant | Stock Option (Right to Buy) | — | +180K | 180,000 0.30% of shares | low |
| Jan 16, 2026 | Fabbio Patrick Executive | Grant | Stock Option (Right to Buy) | — | +175K | 175,000 0.30% of shares | low |
| Jan 16, 2026 | Conkling William Executive | Grant | Stock Option (Right to Buy) | — | +158K | 158,000 0.27% of shares | low |
| Jan 16, 2026 | Fry Hannah Executive | Grant | Stock Option (Right to Buy) | — | +55K | 55,000 0.09% of shares | low |
| Jan 16, 2026 | Nicacio Leonardo Viana Executive | Grant | Stock Option (Right to Buy) | — | +158K | 158,000 0.27% of shares | low |